Computer system for children with brain conditions, with follow-up tracking
Builds a computer system to support care of children with brain conditions.
Plain-language title generated from the registry record
Registry title: Development and Application of a Diagnosis and Treatment System for Children's Brain Diseases Based on Knowledge Graphs and Large Models
Key facts
- Where
- Nanjing, ChinaSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 18 years old?
Source: NCT06848959, who can take part
Where in China
- Jiangsu Provincial Hospital of Traditional Chinese MedicineNanjing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Yun Liu,PhD
- Trial code
- NCT06848959
- Record updated
- 27 February 2025
- Original description
Using the knowledge graph and big model technology of combining Chinese and Western medicine we construct a popularization and prevention system for childhood encephalopathy an assisted decision-making system for childhood encephalopathy and a follow-up tracking question and answer system for childhood encephalopathy patients.Read full original descriptionShow less
Jiangsu Provincial Hospital of Traditional Chinese Medicine
Using the knowledge graph and big model technology of combining Chinese and Western medicine we construct a popularization and prevention system for childhood encephalopathy an assisted decision-making system for childhood encephalopathy and a follow-up tracking question and answer system for childhood encephalopathy patients.
Inclusion: 1. meet diagnostic criteria for CP ID TD ADHD ASD; 2. gender is not limited.
Exclusion: 2. Children with other major mental illnesses (e.g. schizophrenia) or organic diseases (e.g. congenital heart disease); 1. CP ID TD ASD due to chorea hepatomegaly hearing abnormality and pharmacogenetic factors.